Moderna, Inc. announced its financial results for the first quarter ending March 31, 2025, highlighting a strategic realignment towards oncology and other pipeline candidates amidst declining revenues compared to the previous year.
Financial Highlights
Revenue: The company reported total revenue of $108 million for Q1 2025, a decrease from $167 million in the same period of 2024. This reflects the ongoing transition in the COVID-19 vaccine market.
Net Loss: Moderna posted a GAAP net loss of $(1.0) billion for the quarter.
Earnings Per Share (EPS): The GAAP diluted loss per share was $(2.52).
Strategic Updates & Outlook
In addition to the financial outcomes, Moderna highlighted a major change in strategy to deal with the changing market. This entails putting policies in place to cut operating costs while giving investments first priority, especially in its exciting oncology programs. A number of cancer candidates are among the ten items the company hopes to bring toward regulatory approval as part of its aggressive development pipeline. Moderna’s management expressed confidence in its long-term plan and strong financial position, despite the quarterly loss and lower revenue compared to the previous year.
The reaffirmation of their full-year 2025 financial guidance, which maintains an anticipated revenue range of $1.5 billion to $2.5 billion and projects an end-of-year cash balance of roughly $6 billion, serves as the foundation for this confidence. The Q1 results, taken as a whole, highlight Moderna’s continuous transition phase as it adjusts to the post-pandemic environment. The company is investing heavily in creating additional mRNA-based treatments and vaccines outside of COVID-19, with a particular focus on its oncology portfolio.
Last Modified:
Graduated from the University of Kerala with B.Sc. Botany and Biotechnology. Attained Post-Graduation in Biotechnology from the Kerala University of Fisheries and Ocean Science (KUFOS) with the third rank. Conducted various seminars and attended major Science conferences. Done 6 months of internship in ICMR – National Institute of Nutrition, Hyderabad. 5 years of tutoring experience.
